3/25
10:59 am
crl
Drug Discovery Services Market worth US$27.23 billion in 2030 with 10.7% CAGR | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
Drug Discovery Services Market worth US$27.23 billion in 2030 with 10.7% CAGR | MarketsandMarkets™ [Yahoo! Finance]
3/25
08:34 am
crl
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform [Yahoo! Finance]
Medium
Report
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform [Yahoo! Finance]
3/25
08:00 am
crl
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
Medium
Report
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
3/21
08:09 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $170.00 price target on the stock, down previously from $19
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $170.00 price target on the stock, down previously from $19
3/20
07:16 am
crl
3 Reasons CRL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
Medium
Report
3 Reasons CRL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]
3/18
08:08 pm
crl
Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way? [Yahoo! Finance]
Low
Report
Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way? [Yahoo! Finance]
3/18
06:44 am
crl
Nutraceutical Product Testing Market Report 2025, with Profiles of Auriga Research, Beaconpoint Labs, Certified Laboratories, Dyad Labs, Eurofins Scientific, FARE Labs, RSSL, SGS, SIMA LABS & more [Yahoo! Finance]
Low
Report
Nutraceutical Product Testing Market Report 2025, with Profiles of Auriga Research, Beaconpoint Labs, Certified Laboratories, Dyad Labs, Eurofins Scientific, FARE Labs, RSSL, SGS, SIMA LABS & more [Yahoo! Finance]
3/11
08:00 am
crl
Charles River Laboratories to Present at Barclays Global Healthcare Conference
Medium
Report
Charles River Laboratories to Present at Barclays Global Healthcare Conference
3/5
06:44 am
crl
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4 [Yahoo! Finance]
Low
Report
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4 [Yahoo! Finance]
3/4
07:24 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at Citigroup Inc. from a "sell" rating to a "neutral" rating. They now have a $175.00 price target on the stock, up previously from $155.00.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at Citigroup Inc. from a "sell" rating to a "neutral" rating. They now have a $175.00 price target on the stock, up previously from $155.00.
3/3
07:24 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at Redburn Atlantic from a "sell" rating to a "neutral" rating. They now have a $188.00 price target on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at Redburn Atlantic from a "sell" rating to a "neutral" rating. They now have a $188.00 price target on the stock.
2/26
07:08 pm
crl
Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture [Yahoo! Finance]
Low
Report
Charles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole Picture [Yahoo! Finance]
2/25
12:05 pm
crl
Viral Inactivation Market Analysis Report 2025-2030: Increasing Demand for Biopharmaceuticals, and Technological Advancements in Viral Inactivation Fueling Growth [Yahoo! Finance]
Low
Report
Viral Inactivation Market Analysis Report 2025-2030: Increasing Demand for Biopharmaceuticals, and Technological Advancements in Viral Inactivation Fueling Growth [Yahoo! Finance]
2/25
08:53 am
crl
Charles River Announces Agreement with Singapore General Hospital [Yahoo! Finance]
Low
Report
Charles River Announces Agreement with Singapore General Hospital [Yahoo! Finance]
2/25
08:00 am
crl
Charles River Announces Agreement with Singapore General Hospital
Low
Report
Charles River Announces Agreement with Singapore General Hospital
2/24
11:50 am
crl
Deciphering Charles River (CRL) International Revenue Trends [Yahoo! Finance]
Low
Report
Deciphering Charles River (CRL) International Revenue Trends [Yahoo! Finance]
2/20
10:55 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at JPMorgan Chase & Co. from $175.00 to $165.00. They now have a "neutral" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at JPMorgan Chase & Co. from $175.00 to $165.00. They now have a "neutral" rating on the stock.
2/20
09:31 am
crl
SCbio 2025 Conference Showcases the Future of Life Sciences in South Carolina [Yahoo! Finance]
Low
Report
SCbio 2025 Conference Showcases the Future of Life Sciences in South Carolina [Yahoo! Finance]
2/20
08:00 am
crl
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Robert W. Baird from $177.00 to $173.00. They now have a "neutral" rating on the stock.
Low
Report
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Robert W. Baird from $177.00 to $173.00. They now have a "neutral" rating on the stock.
2/20
02:22 am
crl
Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
Low
Report
Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
2/20
12:48 am
crl
Q4 2024 Charles River Laboratories International Inc Earnings Call [Yahoo! Finance]
Low
Report
Q4 2024 Charles River Laboratories International Inc Earnings Call [Yahoo! Finance]
2/19
05:39 pm
crl
Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance [Yahoo! Finance]
Low
Report
Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance [Yahoo! Finance]
2/19
04:21 pm
crl
CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall [Yahoo! Finance]
Low
Report
CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall [Yahoo! Finance]
2/19
03:38 pm
crl
Charles River Laboratories International, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Charles River Laboratories International, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/19
03:06 pm
crl
Charles River Laboratories targets $9.10-$9.60 EPS in 2025 amid cost optimization efforts [Seeking Alpha]
Low
Report
Charles River Laboratories targets $9.10-$9.60 EPS in 2025 amid cost optimization efforts [Seeking Alpha]